| Kathleen Harden, | |
|
4700 Waters Ave, Savannah, GA 31404-6220 | |
| (912) 350-8383 | |
| Not Available |
| Full Name | Kathleen Harden |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 4700 Waters Ave, Savannah, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093405698 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | RN231716 (Georgia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | RN231716 (Georgia) | Primary |
| Entity Name | Coastal Cancer Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205104783 PECOS PAC ID: 7315182169 Enrollment ID: O20130326000531 |
News Archive
Emergent BioSolutions Inc. announced today its financial results for the first quarter ended March 31, 2012.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.
HCA today announced that it intends to offer $1.0 billion aggregate principal amount of senior secured first lien notes due 2020 (the "Notes"). In accordance with the terms of its senior secured credit facilities, HCA will use the net proceeds from the offering to repay term loans under its cash flow credit facility.
Dr. Reddy's Laboratories announced today that it has launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Zometa® (zoledronic acid) 4 mg/5 mL Injection in the US market on March 4, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Zoledronic Acid Injection (4 mg/5 mL).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Harden, 1008 Pine Needle Dr, Savannah, GA 31410-2707 Ph: (912) 665-0215 | Kathleen Harden, 4700 Waters Ave, Savannah, GA 31404-6220 Ph: (912) 350-8383 |
News Archive
Emergent BioSolutions Inc. announced today its financial results for the first quarter ended March 31, 2012.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.
HCA today announced that it intends to offer $1.0 billion aggregate principal amount of senior secured first lien notes due 2020 (the "Notes"). In accordance with the terms of its senior secured credit facilities, HCA will use the net proceeds from the offering to repay term loans under its cash flow credit facility.
Dr. Reddy's Laboratories announced today that it has launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Zometa® (zoledronic acid) 4 mg/5 mL Injection in the US market on March 4, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Zoledronic Acid Injection (4 mg/5 mL).
› Verified 5 days ago
Glenda Laine Eloge, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5353 Reynolds St, Ste 300, Savannah, GA 31405 Phone: 912-355-6005 Fax: 912-355-5643 | |
Ms. Deborah Evelyn Kemp, APRN, BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1302 Drayton St, Savannah, GA 31401 Phone: 912-443-9409 Fax: 912-443-1843 | |
Deanna M Wildes, RN, BSN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4750 Waters Avenue, Suite 500, Savannah, GA 31404 Phone: 912-352-8346 Fax: 912-355-1414 | |
Abegail Delez Xiang, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6301 Abercorn St, Savannah, GA 31405 Phone: 912-352-8700 Fax: 912-650-6805 | |
Jackie M Kehrli, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4750 Waters Ave Ste 202, Savannah, GA 31404 Phone: 912-350-7412 Fax: 912-350-7297 | |
Caroline Shealy Sauers, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6602 Waters Ave Bldg C, Savannah, GA 31406 Phone: 912-354-7676 Fax: 912-354-6040 | |
Stacy Eagle, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6602 Waters Ave, Savannah, GA 31406 Phone: 912-354-7676 |